Video Guide

Catalyst Database

Chronological list of catalyst events. Click "See Drug Details" to view detailed info in our AmpCard. Use the Sort options or search box below (e.g. "Phase 2") to filter the catalyst results.

Sort Table By:

Ticker

Catalyst Date

Ticker

Drug | Disease (links)

Stage (next event)

Catalyst Date

CYDY

Phase 3 (Interim Analysis)

Leronlimab (PRO 140)

COVID-19

January 22, 2021 (Est)

AUPH

PDUFA

Voclosporin

Lupus Nephritis

Jan 22, 2021

7/22/00 FDA accepted NDA filing and granted priority review - PDUFA set for 1/22/01

Approval Decision

IRWD

Approved

Linzess®

Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC)

January 29, 2021 (Est)

Quarterly Sales

LOGC

Phase 1/2

LB-001

MMA (Methylmalonic Acidemia)

Early 2021

Initiation

ENLV

Phase 2b

Allocetra (Immunotherapy)

Treatment of organ failure associated with Sepsis

Q4 2020

Still waiting on Phase 2b update

Initiation

VNDA

Quarterly Sales (Approved)

Fanapt® (iloperidone)

Schizophrenia

January 2021

ALT

Phase 1b

NasoShield (Vaccine)

Anthrax Vaccine

January 2021 (Est)

TGTX

Phase 3 (Regulatory Submission)

TG-1101 and TG-1202 (UNITY)

Chronic Lymphocytic Leukemia (CLL) (FL & R/R)

January 2021 (Est)

NKTR

Phase 1/2

Bempegaldesleukin+ KEYTRUDA® (pembrolizumab) (PROPEL)

Non-Small Cell Lung Cancer (NSCLC)

January 2021 (Est)

Preliminary ORR for 10-20 patients (CEO 8/7/20)

Data Readout

CHRS

Phase 3 (BLA Filing)

Innovent’s Avastin® Biosimilar (bevacizumab)

Non-small-cell lung carcinoma (NSCLC)

Early 2021

Amp Volatility is calculated based off of options pricing with expiration after event.
Last Calculated: 03/13/20